{"id":"https://openalex.org/W3211857930","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.392","title":"392 A phase 1a/b study of IK-175, an oral AHR inhibitor, alone and in combination with nivolumab in patients with locally dvanced or metastatic solid tumors and urothelial carcinoma","display_name":"392 A phase 1a/b study of IK-175, an oral AHR inhibitor, alone and in combination with nivolumab in patients with locally dvanced or metastatic solid tumors and urothelial carcinoma","publication_year":2021,"publication_date":"2021-11-01","ids":{"openalex":"https://openalex.org/W3211857930","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.392","mag":"3211857930"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2021-sitc2021.392","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.392","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.392","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A425.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A425.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002575629","display_name":"Meredith Ann McKean","orcid":"https://orcid.org/0000-0003-0944-7418","observed_orcids":["https://orcid.org/0000-0003-0944-7418"]},"institutions":[{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meredith McKean","raw_affiliation_strings":["Tennessee Oncology, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tennessee Oncology, Nashville, TN, USA","institution_ids":["https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063337705","display_name":"Jason J. Luke","orcid":"https://orcid.org/0000-0002-1182-4908","observed_orcids":["https://orcid.org/0000-0002-1182-4908"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Luke","raw_affiliation_strings":["UPMC Hillman Cancer Center, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UPMC Hillman Cancer Center, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003770647","display_name":"Nehal J. Lakhani","orcid":"https://orcid.org/0009-0005-6327-0176","observed_orcids":["https://orcid.org/0009-0005-6327-0176"]},"institutions":[{"id":"https://openalex.org/I4210158030","display_name":"Start Treatment & Recovery Centers","ror":"https://ror.org/05km40z28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210158030"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nehal Lakhani","raw_affiliation_strings":["START Midwest, Grand Rapids, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"START Midwest, Grand Rapids, MI, USA","institution_ids":["https://openalex.org/I4210158030"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070439273","display_name":"Babar Bashir","orcid":"https://orcid.org/0000-0002-6843-1179","observed_orcids":["https://orcid.org/0000-0002-6843-1179"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Babar Bashir","raw_affiliation_strings":["Thomas Jefferson University, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thomas Jefferson University, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I149251103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067522153","display_name":"David Henry Aggen","orcid":"https://orcid.org/0000-0003-3963-5751","observed_orcids":["https://orcid.org/0000-0003-3963-5751"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Aggen","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076269626","display_name":"Alan Tan","orcid":"https://orcid.org/0000-0001-5925-8565","observed_orcids":["https://orcid.org/0000-0001-5925-8565"]},"institutions":[{"id":"https://openalex.org/I49886154","display_name":"Rush University","ror":"https://ror.org/01k9xac83","country_code":"US","type":"education","lineage":["https://openalex.org/I49886154"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Tan","raw_affiliation_strings":["Rush University, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rush University, Chicago, IL, USA","institution_ids":["https://openalex.org/I49886154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088915722","display_name":"Katherine A. Kacena","orcid":"https://orcid.org/0000-0002-2038-692X","observed_orcids":["https://orcid.org/0000-0002-2038-692X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katherine Kacena","raw_affiliation_strings":["Katherine Kacena Consulting, Natick, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Katherine Kacena Consulting, Natick, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100435903","display_name":"Lei Wang","orcid":"https://orcid.org/0000-0002-3392-3712","observed_orcids":["https://orcid.org/0000-0002-3392-3712"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lei Wang","raw_affiliation_strings":["Ikena Oncology, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ikena Oncology, Boston, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075768261","display_name":"Marissa Timothy","orcid":"https://orcid.org/0000-0001-9257-2388","observed_orcids":["https://orcid.org/0000-0001-9257-2388"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marissa Timothy","raw_affiliation_strings":["Ikena Oncology, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ikena Oncology, Boston, MA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Sergio Santillana","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sergio Santillana","raw_affiliation_strings":["Ikena Oncology, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ikena Oncology, Boston, MA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A425","last_page":"A425"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.010599999688565731,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9860000014305115},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.8479999899864197},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.6620000004768372},{"id":"https://openalex.org/keywords/kynurenine","display_name":"kynurenine","score":0.6710000038146973},{"id":"https://openalex.org/keywords/ido1","display_name":"IDO1","score":0.7590000033378601},{"id":"https://openalex.org/keywords/tryptophan-2-3-dioxygenase","display_name":"tryptophan 2,3-dioxygenase","score":0.9150000214576721},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.7200000286102295},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6150000095367432},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5619999766349792},{"id":"https://openalex.org/keywords/oral-small-molecule","display_name":"oral small molecule","score":0.5009999871253967},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.777999997138977},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8999999761581421},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9490000009536743},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7710000276565552},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6102105379104614},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6079354882240295},{"id":"https://openalex.org/C33594762","wikidata":"https://www.wikidata.org/wiki/Q155750","display_name":"Aryl hydrocarbon receptor","level":4,"score":0.5436888933181763},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5241183042526245},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.48993247747421265},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43567901849746704},{"id":"https://openalex.org/C193270364","wikidata":"https://www.wikidata.org/wiki/Q17141925","display_name":"Tissue microarray","level":3,"score":0.42850616574287415},{"id":"https://openalex.org/C2777503454","wikidata":"https://www.wikidata.org/wiki/Q415768","display_name":"Kynurenine","level":4,"score":0.42425987124443054},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37689208984375},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3305562436580658},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29938817024230957},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.2635660767555237},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2523359954357147},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.11914607882499695},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.0},{"id":"https://openalex.org/C2776706248","wikidata":"https://www.wikidata.org/wiki/Q181003","display_name":"Tryptophan","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2021-sitc2021.392","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.392","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.392","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A425.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:05aab1271bb545dca1191f26e39af1ca","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/05aab1271bb545dca1191f26e39af1ca","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2021-sitc2021.392","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.392","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.392","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A425.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3211857930.pdf","grobid_xml":"https://content.openalex.org/works/W3211857930.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4286298943","https://openalex.org/W4308398705","https://openalex.org/W4399614805","https://openalex.org/W4415816112","https://openalex.org/W3104234776","https://openalex.org/W3211976744","https://openalex.org/W4282930398","https://openalex.org/W3212079980","https://openalex.org/W3151647854","https://openalex.org/W3135671090"],"abstract_inverted_index":{"Background":[0],"Aryl":[1],"Hydrocarbon":[2],"Receptor":[3],"(AHR)":[4],"is":[5,60,159,171,344,396],"a":[6,44,61,105,172,206,316,334,354,438],"transcription":[7],"factor":[8],"that":[9,131,262],"regulates":[10],"the":[11,135,184,276,362,416],"activity":[12,103,194],"of":[13,38,138,148,195,220,270,300,330,367,377,418,434],"multiple":[14,56,115],"innate":[15],"and":[16,25,35,87,98,142,179,191,209,233,284,302,374,379,384,395,405],"adaptive":[17],"immune":[18],"cells":[19,347],"after":[20],"binding":[21],"to":[22,40,43,89,182,403,408,415],"several":[23],"endogenous":[24],"exogenous":[26],"ligands,":[27],"including":[28],"kynurenine,":[29],"generated":[30],"from":[31],"tryptophan":[32],"by":[33,275,313,353],"IDO1":[34],"TDO2.":[36],"Binding":[37],"kynurenine":[39],"AHR":[41,50,65,119,139,143,150,154,310,336,343,352,442],"leads":[42,88],"net":[45],"immunosuppressive":[46],"tumor":[47,117,122,128,309,346],"microenvironment,":[48],"making":[49],"an":[51,70,79,90,146],"attractive":[52],"therapeutic":[53],"target":[54],"in":[55,92,109,114,155,200,210,223,238,319,324,361,392],"cancer":[57,133],"types.":[58],"IK-175":[59,77,100,196,292,368],"selective,":[62],"small":[63],"molecule":[64],"inhibitor":[66],"being":[67,160],"developed":[68],"as":[69,96,104,205,315],"oral":[71],"(PO)":[72],"agent.":[73],"In":[74],"human":[75],"T-cells,":[76],"induces":[78],"activated":[80],"T-cell":[81],"state,":[82],"interleukin":[83],"(IL)-22":[84],"gene":[85],"expression,":[86],"increase":[91],"proinflammatory":[93],"cytokines,":[94],"such":[95],"IL-2":[97],"IL-9.":[99],"demonstrates":[101],"antitumor":[102,193],"single":[106,207],"agent":[107],"or":[108,202,259,266],"combination":[110,211,363],"with":[111,167,212,227,247,321,382],"checkpoint":[112],"inhibitors":[113],"mouse":[116],"models.1":[118],"immunohistochemistry":[120],"(IHC)":[121],"microarray":[123],"analysis":[124],"across":[125],"15":[126],"different":[127],"types":[129],"revealed":[130],"bladder":[132],"has":[134],"highest":[136],"level":[137],"protein":[140],"expression":[141],"nuclear":[144,153,311,337,351],"localization,":[145],"indicator":[147],"active":[149,441],"signaling.":[151],"Therefore,":[152],"urothelial":[156,234,253,322],"carcinoma":[157,235,323],"tumors":[158,230,251],"investigated":[161],"for":[162,341,349,412],"potential":[163],"predictive":[164,317,378],"clinical":[165,435],"benefit":[166],"IK-175.":[168],"Methods":[169],"This":[170],"first-in-human,":[173],"phase":[174],"1a/b,":[175],"open-label,":[176],"multicenter,":[177],"dose-escalation":[178],"expansion":[180],"study":[181,306,390],"evaluate":[183],"safety,":[185],"tolerability,":[186],"pharmacokinetics":[187],"(PK),":[188],"pharmacodynamics":[189],"(PD),":[190],"preliminary":[192,303],"administered":[197],"PO":[198],"daily":[199],"21":[201],"28":[203],"day-cycle":[204],"agent,":[208],"nivolumab,":[213],"480":[214],"mg":[215],"q4w":[216],"on":[217,265,295],"Day":[218],"1":[219],"every":[221],"cycle,":[222],"93":[224],"adult":[225],"patients":[226,246,320,332],"advanced":[228],"solid":[229,250],"(dose":[231,236],"escalation)":[232],"expansion)":[237],"both":[239,296,325],"treatment":[240,297,326],"arms.":[241,327],"Key":[242,288],"eligibility":[243],"criteria":[244],"include":[245,281,291],"histologically":[248],"confirmed":[249],"(including":[252],"carcinoma)":[254],"who":[255],"have":[256,263],"locally":[257],"recurrent":[258],"metastatic":[260],"disease":[261],"progressed":[264],"following":[267],"all":[268],"standard":[269],"care":[271],"therapies":[272],"deemed":[273],"appropriate":[274],"treating":[277],"physician.":[278],"Primary":[279],"endpoints":[280,290],"dose-limiting":[282],"toxicities":[283],"treatment-emergent":[285],"adverse":[286],"events.":[287],"secondary":[289],"PK":[293],"profile":[294],"arms,":[298],"PD":[299,370,380],"IK-175,":[301,437],"efficacy.":[304],"The":[305,389],"will":[307,358,386],"explore":[308],"localization":[312,338],"IHC":[314,356],"biomarker":[318],"A":[328],"minimum":[329],"10":[331],"having":[333],"positive":[335,342,348],"test":[339],"(cutoff":[340],"65%":[345],"2+/3+":[350],"validated":[355],"assay)":[357],"be":[359,387],"enrolled":[360],"arm.":[364],"Exploratory":[365],"biomarkers":[366],"mediated":[369],"effects,":[371],"PK-PD":[372],"correlations,":[373],"correlative":[375],"analyses":[376],"measurements":[381],"response":[383],"resistance":[385],"performed.":[388],"started":[391],"January":[393],"2020":[394],"ongoing":[397],"Acknowledgements":[398],"Ikena":[399],"Oncology":[400],"would":[401],"like":[402],"recognize":[404],"express":[406],"gratitude":[407],"Dr.":[409],"Jason":[410],"Sager":[411],"his":[413],"contributions":[414],"implementation":[417],"this":[419],"trial.":[420],"Trial":[421],"Registration":[422],"clinicaltrials.gov":[423],"registration:":[424],"NCT04200963":[425],"Reference":[426],"McGovern":[427],"K,":[428],"Castro":[429],"A,":[430],"Cavanaugh":[431],"J,":[432],"Discovery":[433],"candidate":[436],"selective":[439],"orally":[440],"antagonist.":[443],"SITC":[444],"2020,":[445],"poster":[446],"presentation.":[447]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2021-11-22T00:00:00"}